| Date Filed | Type | Description |
| 08/23/2023 |
4
| Rodriguez Susan (Chief Commercial Officer) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Sold 4,733 shares
@ $3.5518, valued at
$16.8k
|
|
| 05/25/2023 |
4
| Rodriguez Susan (Chief Commercial Officer) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Sold 4,711 shares
@ $3.6532, valued at
$17.2k
|
|
| 03/02/2023 |
4
| Rodriguez Susan (Chief Commercial Officer) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Sold 5,586 shares
@ $3.001, valued at
$16.8k
|
|
| 02/27/2023 |
3
| Rodriguez Susan (Director) has filed a Form 3 on Veradigm Inc. |
| 01/06/2023 |
4
| Rodriguez Susan (Chief Commercial Officer) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 78,000 shares
@ $0
Granted 351,000 options to buy
@ $2.73, valued at
$958.2k
|
|
| 12/20/2022 |
4
| Rodriguez Susan (Director) has filed a Form 4 on HERON THERAPEUTICS, INC. /DE/|
Txns:
| Granted 38,580 shares
@ $0
Granted 77,160 options to buy
@ $2.74, valued at
$211.4k
|
|
| 11/23/2022 |
4
| Rodriguez Susan (Chief Commercial Officer) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Sold 131 shares
@ $1.9418, valued at
$254.4
Sold 22 shares
@ $1.945, valued at
$42.8
Sold 3,303 shares
@ $1.9493, valued at
$6.4k
|
|
| 08/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/23/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/12/2022 |
4
| Rodriguez Susan (Chief Commercial Officer) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 141,000 shares
@ $0
Granted 195,000 options to buy
@ $0.99, valued at
$193.1k
|
|
| 12/23/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 11/24/2021 |
4
| Rodriguez Susan (Chief Commercial Officer) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Sold 643 shares
@ $0.9919, valued at
$637.8 |
|
| 10/29/2021 |
4
| Rodriguez Susan (Chief Commercial Officer) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 150,000 shares
@ $0 |
|
| 09/29/2021 |
3
| Rodriguez Susan (Director) has filed a Form 3 on HERON THERAPEUTICS, INC. /DE/ |
| 08/24/2021 |
4
| Rodriguez Susan (Chief Commercial Officer) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Sold 630 shares
@ $1.32, valued at
$831.6 |
|
| 05/21/2021 |
4
| Rodriguez Susan (Chief Commercial Officer) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Sold 611 shares
@ $7.0878, valued at
$4.3k
|
|
| 02/24/2021 |
4
| Rodriguez Susan (Chief Commercial Officer) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Sold 611 shares
@ $6.8825, valued at
$4.2k
|
|
| 01/07/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 09/17/2020 |
4
| Rodriguez Susan (Chief Commercial Officer) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Sold 6,087 shares
@ $6.1055, valued at
$37.2k
|
|
| 05/20/2020 |
4
| Rodriguez Susan (Chief Commercial Officer) has filed a Form 4 on ARDELYX, INC.|
Txns:
| Granted 20,000 shares
@ $0
Granted 232,750 options to buy
@ $7.7, valued at
$1.8M
|
|
| 05/19/2020 |
3
| Rodriguez Susan (Chief Commercial Officer) has filed a Form 3 on ARDELYX, INC. |